title: 1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes.
abstract: Increased accumulation of macrophages in adipose tissue in obesity is linked to low-grade chronic inflammation, and associated with features of metabolic syndrome. Vitamin D3 may have immunoregulatory effects and reduce adipose tissue inflammation, although the molecular mechanisms remain to be established. This study investigated the effects of vitamin D3 on macrophage-elicited inflammatory responses in cultured human adipocytes, particularly the signalling pathways involved. Macrophage-conditioned (MC) medium (25% with adipocyte maintenance media) markedly inhibited protein expression of the nuclear factor-κB (NFκB) subunit inhibitor κBα (IκBα) (71%, P<0.001) and increased NFκB p65 (1.5-fold, P = 0.026) compared with controls. Treatment with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) abolished macrophage-induced activation of NFκB signalling by increasing IκBα expression (2.7-fold, P = 0.005) and reducing NFκB p65 phosphorylation (68%; P<0.001). The mitogen-activated protein kinase (MAPK) signalling was activated by MC medium, which was also blunted by 1,25(OH)2D3 with a downregulation of phosphorylated p38 MAPK (32%, P = 0.005) and phosphorylated Erk1/2 (49%, P = 0.001). Furthermore, MC medium (12.5% or 25%) dose-dependently upregulated secretion of key proinflammatory chemokines/cytokines (22-368-fold; all P<0.001) and this was significantly decreased by 1,25(OH)2D3: IL-8 (61% and 31%, P<0.001), MCP-1 (37%, P<0.001 and 36%, P = 0.002), RANTES (78% and 62%, P<0.001) and IL-6 (29%, P<0.001 and 34%, P = 0.019). Monocyte migration-elicited by adipocytes treated with 1,25(OH)2D3 was also reduced (up to 25%, P<0.001). In conclusion, vitamin D3 could be anti-inflammatory in adipose tissue, decreasing macrophage-induced release of chemokines and cytokines by adipocytes and the chemotaxis of monocytes. Our data suggests these effects are mediated by inhibition of the NFκB and MAPK signalling pathways.
authors: Obesity Biology Research Unit, Department of Obesity and Endocrinology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
authors: Cherlyn
authors: C
authors: Ding
authors: John P H
authors: JP
authors: Wilding
authors: Chen
authors: C
authors: Bing
mesh_terms: D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism*; D000328:Adult; D000818:Animals; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D018925:Chemokines / Q000096:biosynthesis*; D016207:Cytokines / Q000096:biosynthesis; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D006801:Humans; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects*; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D018925:Chemokines; D016207:Cytokines; D016328:NF-kappa B; C118756:dihydroxy-vitamin D3; D014807:Vitamin D; D020928:Mitogen-Activated Protein Kinases
references: Am J Clin Nutr. 2004 May;79(5):820-5
references: 15113720
references: J Clin Invest. 2007 Apr;117(4):902-9
references: 17364026
references: Inflamm Bowel Dis. 2008 May;14(5):597-604
references: 18200516
references: Circulation. 2007 Feb 27;115(8):946-8
references: 17325252
references: Int J Obes (Lond). 2013 May;37(5):651-7
references: 22828938
references: Int J Obes (Lond). 2013 Mar;37(3):357-65
references: 22508334
references: Recent Results Cancer Res. 2003;164:29-42
references: 12899512
references: J Steroid Biochem Mol Biol. 2009 Jan;113(1-2):134-8
references: 19138739
references: J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33
references: 17164304
references: J Immunol. 2012 Mar 1;188(5):2127-35
references: 22301548
references: Diabetes Metab. 2009 Sep;35(4):251-60
references: 19539513
references: FASEB J. 2012 Nov;26(11):4400-7
references: 22798425
references: Diabetes. 2012 Jul;61(7):1680-90
references: 22474027
references: J Cell Physiol. 2011 Nov;226(11):2869-80
references: 21935932
references: Lipids Health Dis. 2011 Feb 27;10:37
references: 21352586
references: Mol Cell Endocrinol. 2010 Aug 30;325(1-2):135-42
references: 20595026
references: Trends Immunol. 2004 Jun;25(6):280-8
references: 15145317
references: Cell. 1995 Dec 15;83(6):835-9
references: 8521507
references: Annu Rev Immunol. 2011;29:415-45
references: 21219177
references: J Lipid Res. 2008 Sep;49(9):1894-903
references: 18503031
references: Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):39-45
references: 19893003
references: Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E8-13
references: 13129857
references: J Cell Biochem. 2011 Nov;112(11):3393-405
references: 21769914
references: Thorax. 2008 Sep;63(9):784-90
references: 18492738
references: Diabetes. 2009 Aug;58(8):1780-8
references: 19509023
references: BMC Med. 2011 Jul 12;9:85
references: 21749681
references: Endocrine. 2008 Feb;33(1):90-4
references: 18338271
references: Obes Surg. 2008 Feb;18(2):145-50
references: 18175194
references: Diabetes Metab. 2011 Sep;37(4):283-90
references: 21507694
references: Eur J Nutr. 2012 Apr;51(3):335-42
references: 21701898
references: Mol Endocrinol. 2009 Jan;23(1):11-24
references: 18945811
references: Stroke. 2011 Jan;42(1):65-72
references: 21148444
references: J Clin Endocrinol Metab. 1991 Jan;72(1):157-64
references: 1986015
references: Am J Clin Nutr. 2000 Sep;72(3):690-3
references: 10966885
references: J Nutr Biochem. 2008 Jun;19(6):392-9
references: 17869082
references: PLoS One. 2012;7(12):e52171
references: 23272223
references: Int J Obes (Lond). 2005 Nov;29(11):1299-307
references: 15997242
references: Nephrol Dial Transplant. 2006 Apr;21(4):889-97
references: 16455676
references: J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):462-6
references: 20399270
references: Curr Drug Targets. 2011 Jan;12(1):4-18
references: 20795941
references: Br J Nutr. 2012 Dec 14;108(11):1915-23
references: 23046765
references: J Clin Endocrinol Metab. 2012 Jan;97(1):279-85
references: 22072738
references: Endocrinology. 2007 Jun;148(6):2955-62
references: 17317777
references: Diabetes Res Clin Pract. 2007 Jul;77(1):47-57
references: 17112620
references: Intern Med J. 2009 Apr;39(4):256-8
references: 19402866
references: FEBS Lett. 2005 Jan 3;579(1):41-7
references: 15620688
references: J Clin Invest. 2006 Jun;116(6):1494-505
references: 16691291
references: J Surg Res. 2010 Dec;164(2):198-202
references: 20850786
references: Diabetes. 2005 Dec;54 Suppl 2:S114-24
references: 16306329
references: J Steroid Biochem Mol Biol. 2007 Jan;103(1):51-60
references: 17049230
references: Clin Cancer Res. 2008 Nov 1;14(21):6735-41
references: 18980965
references: Nutr Rev. 1976 Nov;34(11):338-40
references: 794773
references: J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):558-62
references: 17267205
references: Breast Cancer Res Treat. 2012 Feb;131(3):1003-12
references: 22002519
references: J Biol Chem. 2006 Sep 8;281(36):26602-14
references: 16809344
references: J Am Soc Nephrol. 2010 Jun;21(6):966-73
references: 20378820
references: Arthritis Res. 2002;4(3):157-64
references: 12010565
references: Mol Nutr Food Res. 2012 Dec;56(12):1771-82
references: 23065818
references: Ann N Y Acad Sci. 2006 Apr;1068:204-13
references: 16831920
references: Circulation. 2007 Feb 27;115(8):1029-38
references: 17296858
references: J Clin Invest. 2001 Jan;107(1):7-11
references: 11134171
references: Diabetes. 2007 Apr;56(4):1010-3
references: 17287468
references: J Clin Invest. 2006 Jan;116(1):115-24
references: 16341265
references: J Biol Chem. 2009 Jul 31;284(31):20692-8
references: 19494115